Showing 2801-2810 of 7783 results for "".
EBDs, CBD, Millennials, and More in the Mix at CSF
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/ebds-cbd-millennials-and-more-in-the-mix-at-csf/23131/Get the scoop on what will happen live at CSF 2019!MIPS: The Secret to His Success
https://practicaldermatology.com/topics/practice-management/mips-the-secret-to-his-success/23117/Windsor Dermatology’s Dr. David Nieves shares his successful MIPS action plan.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-6/23116/New Products/New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-otc-3/23108/New Products/New In My Practice: Sunscreen
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-sunscreen/23087/You Don’t Have Male
https://practicaldermatology.com/topics/practice-management/you-dont-have-male/23084/Male cosmetic patients are hard to come by. Here’s why!New Products/New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-otc-2/23068/Updates from Principia, Sebacia, and Candela
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-updates-from-principia-sebacia-and-candela/19571/Phase 2 data for from the Believe-PV study for PRN1008 show that the investigational agent from Principia Biopharma reached the primary efficacy measure in pemphigus. Data confirm that Sebacia microparticles confer benefit in the management of acne vulgaris in real-world settings. Candela has rebranRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/22066/New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/22085/